|
|
|
|
|
|
Atara Biotherap Cmn (ATRA)
|
|
14.50 -0.25 (-1.69%)
|
6/23/2017 4:00pm
|
|
Open:
|
14.65
|
Pre. Close:
|
14.75
|
|
High:
|
14.75
|
Low:
|
13.85
|
|
Volume:
|
791,214
|
Market Cap:
|
422.08M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
15.08 - 15.37
|
15.37 - 15.56
|
|
Low:
|
12.9 - 13.27
|
13.27 - 13.51
|
|
Close:
|
13.74 - 14.53
|
14.53 - 15.06
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:32:16 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 18.51 One year: 21.62
|
|
Support:
|
Support1: 13.35 Support2: 11.80
|
|
Resistance:
|
Resistance1:
15.85 Resistance2: 18.51
|
|
Pivot:
|
13.48 
|
|
Moving Averages:
|
MA(5): 14.11 MA(20): 13.59 
MA(100): 16.32 MA(250): 17.86
|
|
MACD:
|
MACD(12,26):
-0.32 Signal(12,26,9): -0.61
|
|
%K %D:
|
%K(14,3): 80.41 %D(3): 74.01
|
|
RSI:
|
RSI(14): 53.23
|
|
52-Week:
|
High: 25.73
Low: 11.80 Change(%): -34.3
|
|
Average Vol(K):
|
3-Month: 296
10-Days 364
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ATRA has closed below upper band by 13.1%. Bollinger Bands are 32.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 10 May 2017 12:00:00 GMT
Atara Biotherapeutics Enhances Commercial Expertise with the Appointment of Dr ...
Wed, 24 May 2017 12:00:00 GMT
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences
Wed, 08 Feb 2017 23:03:45 GMT
Atara Biotherapeutics Coming to Thousand Oaks
Thu, 20 Apr 2017 21:16:25 GMT
Atara Biotherapeutics shares rise on MS drug study results
Mon, 03 Apr 2017 12:03:22 GMT
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
